Cargando…

Antiretroviral Drug Resistance and Routine Therapy, Cameroon

Among 128 patients routinely receiving highly active antiretroviral therapy in an HIV/AIDS outpatient clinic in Cameroon, 16.4% had drug resistance after a median of 10 months. Of these, 12.5% had resistance to nucleoside reverse transcriptase inhibitors (NRTIs), 10.2% to non-NRTIs, and 2.3% to prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laurent, Christian, Kouanfack, Charles, Vergne, Laurence, Tardy, Michèle, Zekeng, Léopold, Noumsi, Nathalie, Butel, Christelle, Bourgeois, Anke, Mpoudi-Ngolé, Eitel, Koulla-Shiro, Sinata, Peeters, Martine, Delaporte, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2006
Materias:	Dispatch
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298273/ https://www.ncbi.nlm.nih.gov/pubmed/16707062 http://dx.doi.org/10.3201/eid1206.050860

Ejemplares similares

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months’ antiretroviral therapy experience in Cameroon
por: Aghokeng, Avelin F, et al.
Publicado: (2013)

Commercial Logging and HIV Epidemic, Rural Equatorial Africa
por: Laurent, Christian, et al.
Publicado: (2004)

HIV and Hepatitis C Virus Coinfection, Cameroon
por: Laurent, Christian, et al.
Publicado: (2007)

Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon
por: Mbougua, Jules B Tchatchueng, et al.
Publicado: (2010)

Inaccurate Diagnosis of HIV-1 Group M and O Is a Key Challenge for Ongoing Universal Access to Antiretroviral Treatment and HIV Prevention in Cameroon
por: Aghokeng, Avelin F., et al.
Publicado: (2009)

Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon
por: Ndongo, Francis Ateba, et al.
Publicado: (2022)

New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon
por: Ndawinz, Jacques DA, et al.
Publicado: (2015)

Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test
por: Temfack, Elvis, et al.
Publicado: (2018)

Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets
por: Boullé, Charlotte, et al.
Publicado: (2016)

Determinants of retention in care in an antiretroviral therapy (ART) program in urban Cameroon, 2003–2005
por: Tsague, Landry, et al.
Publicado: (2008)

Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon
por: Tchouwa, Gaëlle F., et al.
Publicado: (2018)

Noninvasive western lowland gorilla's health monitoring: A decade of simian immunodeficiency virus surveillance in southern Cameroon
por: Villabona‐Arenas, Christian Julian, et al.
Publicado: (2018)

A randomized blinded controlled trial of mobile phone reminders on the follow-up medical care of HIV-exposed and HIV-infected children in Cameroon: study protocol (MORE CARE)
por: Bigna, Jean Joel R, et al.
Publicado: (2013)

Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)
por: Liégeois, Florian, et al.
Publicado: (2020)

Multiplex detection of antibodies to Chikungunya, O’nyong-nyong, Zika, Dengue, West Nile and Usutu viruses in diverse non-human primate species from Cameroon and the Democratic Republic of Congo
por: Raulino, Raisa, et al.
Publicado: (2021)

Molecular Evidence for the Presence of Rickettsia Felis in the Feces of Wild-living African Apes
por: Keita, Alpha Kabinet, et al.
Publicado: (2013)

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa
por: Ciaffi, Laura, et al.
Publicado: (2015)

Dynamics of Antibodies to Ebolaviruses in an Eidolon helvum Bat Colony in Cameroon
por: Djomsi, Dowbiss Meta, et al.
Publicado: (2022)

Exposure to Wild Primates among HIV-infected Persons
por: LeBreton, Matthew, et al.
Publicado: (2007)

Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study
por: Namme Luma, Henry, et al.
Publicado: (2012)

Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
por: Bigna, Jean Joel R., et al.
Publicado: (2016)

Genetic diversity of simian lentivirus in wild De Brazza’s monkeys (Cercopithecus neglectus) in Equatorial Africa
por: Aghokeng, Avelin F., et al.
Publicado: (2010)

Role of Wildlife in Emergence of Ebola Virus in Kaigbono (Likati), Democratic Republic of the Congo, 2017
por: Gryseels, Sophie, et al.
Publicado: (2020)

Central African Hunters Exposed to Simian Immunodeficiency Virus
por: Kalish, Marcia L., et al.
Publicado: (2005)

Risk to Human Health from a Plethora of Simian Immunodeficiency Viruses in Primate Bushmeat
por: Peeters, Martine, et al.
Publicado: (2002)

Survey of Ebola Viruses in Frugivorous and Insectivorous Bats in Guinea, Cameroon, and the Democratic Republic of the Congo, 2015–2017
por: De Nys, Helene M., et al.
Publicado: (2018)

HIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatment
por: Bigna, Jean Joel R., et al.
Publicado: (2015)

Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic
por: Tongo, Marcel, et al.
Publicado: (2013)

Factors associated with non-adherence to scheduled medical follow-up appointments among Cameroonian children requiring HIV care: a case-control analysis of the usual-care group in the MORE CARE trial
por: Bigna, Jean Joel R, et al.
Publicado: (2014)

Barriers to the implementation of mobile phone reminders in pediatric HIV care: a pre-trial analysis of the Cameroonian MORE CARE study
por: Bigna, Jean Joel R, et al.
Publicado: (2014)

Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance
por: Billong, Serge C., et al.
Publicado: (2013)

Chikungunya Virus, Cameroon, 2006
por: Peyrefitte, Christophe N., et al.
Publicado: (2007)

Reemergence of chloroquine-sensitive pfcrt K76 Plasmodium falciparum genotype in southeastern Cameroon
por: Ndam, Nicaise Tuikue, et al.
Publicado: (2017)

Near full-length HIV type 1M genomic sequences from Cameroon : Evidence of early diverging under-sampled lineages in the country
por: Tongo, Marcel, et al.
Publicado: (2015)

Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in Douala, Cameroon: A Cross Sectional Study
por: Luma, Henry Namme, et al.
Publicado: (2013)

The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness
por: Njai, Harr F, et al.
Publicado: (2006)

Human Parvovirus 4 Infection, Cameroon
por: Lavoie, Myriam, et al.
Publicado: (2012)

Exposure to Nonhuman Primates in Rural Cameroon
por: Wolfe, Nathan D., et al.
Publicado: (2004)

Detection of DNA of filariae closely related to Mansonella perstans in faecal samples from wild non-human primates from Cameroon and Gabon
por: Gaillard, Colette Marie, et al.
Publicado: (2020)

Molecular epidemiology of GB type C virus among individuals exposed to hepatitis C virus in Cameroon
por: Torimiro, Judith N., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1cossjlbj76mjtcto4p37680vl